The Limits and Potential Future Applications of Personalized Medicine to Prevent Complex Chronic Disease
The milestone sequencing of the human genome more than a decade ago dawned a genomic revolution with the potential of transforming health. The anticipated benefits included the identification of the early biomarkers of disease, the ability to combine information on risk-conferring genes to improve r...
Saved in:
Published in | Public health reports (1974) Vol. 133; no. 5; pp. 519 - 522 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
Los Angeles, CA
ASSOCIATION OF SCHOOLS & PROGRAMS OF PUBLIC HEALTH
01.09.2018
SAGE Publications SAGE PUBLICATIONS, INC |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The milestone sequencing of the human genome more than a decade ago dawned a genomic revolution with the potential of transforming health. The anticipated benefits included the identification of the early biomarkers of disease, the ability to combine information on risk-conferring genes to improve risk prediction, and the discovery of new disease pathways that can serve as the target for novel therapeutics. Despite monumental breakthroughs, however, genomic science is in its infancy. A gap remains between science and patient benefit. A growing concern is that for the term "personalized medicine" has become a proxy for DNA-centered approaches to prevention and treatment. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0033-3549 1468-2877 |
DOI: | 10.1177/0033354918781568 |